GOLDMAN SACHS GROUP INC - NPS PHARMACEUTICALS INC ownership

NPS PHARMACEUTICALS INC's ticker is P103PS and the CUSIP is 62936P103. A total of 2 filers reported holding NPS PHARMACEUTICALS INC in Q1 2015. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of NPS PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2014$46,240,000
+120.5%
1,292,713
+60.2%
0.01%
+100.0%
Q3 2014$20,975,000
-18.3%
806,756
+3.8%
0.01%
-12.5%
Q2 2014$25,680,000
+328.3%
777,031
+287.9%
0.01%
+300.0%
Q1 2014$5,996,000
-31.3%
200,336
-30.3%
0.00%
-33.3%
Q4 2013$8,725,000
+344.2%
287,398
+365.4%
0.00%
+200.0%
Q3 2013$1,964,000
+169.4%
61,750
+28.1%
0.00%
Q2 2013$729,000
-81.2%
48,201
-88.7%
0.00%
-100.0%
Q4 2012$3,878,000
-37.5%
426,262
-36.4%
0.00%
-50.0%
Q3 2012$6,202,000
-32.1%
670,409
-36.8%
0.00%
-50.0%
Q2 2012$9,131,000
+57.4%
1,060,524
+25.1%
0.00%
+33.3%
Q1 2012$5,800,000847,9950.00%
Other shareholders
NPS PHARMACEUTICALS INC shareholders Q1 2015
NameSharesValueWeighting ↓
Century Capital Management, LLC 97,360$3,483,0000.10%
CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM 387,600$17,799,0000.02%
View complete list of NPS PHARMACEUTICALS INC shareholders